Treace Price To Sales Ratio vs Capex To Depreciation Analysis

TMCI Stock  USD 8.56  0.28  3.38%   
Treace Medical financial indicator trend analysis is much more than just breaking down Treace Medical Concepts prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Treace Medical Concepts is a good investment. Please check the relationship between Treace Medical Price To Sales Ratio and its Capex To Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Price To Sales Ratio vs Capex To Depreciation

Price To Sales Ratio vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Treace Medical Concepts Price To Sales Ratio account and Capex To Depreciation. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Treace Medical's Price To Sales Ratio and Capex To Depreciation is -0.62. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Treace Medical Concepts, assuming nothing else is changed. The correlation between historical values of Treace Medical's Price To Sales Ratio and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Treace Medical Concepts are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Price To Sales Ratio i.e., Treace Medical's Price To Sales Ratio and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

-0.62
Relationship DirectionNegative 
Relationship StrengthWeak

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Treace Medical Concepts stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Treace Medical sales, a figure that is much harder to manipulate than other Treace Medical Concepts multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.
Most indicators from Treace Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Treace Medical Concepts current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
The Treace Medical's current Enterprise Value is estimated to increase to about 1.3 B, while Selling General Administrative is projected to decrease to under 24.1 M.
 2022 2023 2024 (projected)
Depreciation And Amortization4.7M5.4M2.8M
Interest Income910K5.4M5.6M

Treace Medical fundamental ratios Correlations

0.920.990.980.910.90.860.34-0.910.980.320.840.440.930.970.980.990.920.920.970.970.920.951.00.860.99
0.920.950.960.790.750.920.59-0.910.980.060.850.691.00.840.980.950.861.00.960.810.850.990.890.890.9
0.990.951.00.880.830.90.47-0.930.990.170.880.560.950.930.990.980.930.951.00.930.910.980.970.890.97
0.980.961.00.870.810.90.5-0.931.00.150.880.590.960.921.00.980.920.961.00.910.90.990.960.890.96
0.910.790.880.870.850.880.32-0.940.860.340.90.40.820.920.870.860.970.790.850.930.990.830.920.90.92
0.90.750.830.810.850.66-0.04-0.730.810.670.610.070.780.970.810.90.760.750.770.950.80.780.930.640.94
0.860.920.90.90.880.660.7-0.980.91-0.070.980.770.910.780.910.860.950.920.910.760.940.920.830.990.84
0.340.590.470.50.32-0.040.7-0.610.51-0.750.690.990.540.140.510.360.520.590.540.130.450.560.260.70.26
-0.91-0.91-0.93-0.93-0.94-0.73-0.98-0.61-0.93-0.04-0.99-0.68-0.91-0.85-0.94-0.89-0.99-0.9-0.93-0.84-0.98-0.92-0.89-0.99-0.89
0.980.980.991.00.860.810.910.51-0.930.140.870.60.980.911.00.980.910.980.990.890.891.00.950.890.95
0.320.060.170.150.340.67-0.07-0.75-0.040.14-0.09-0.660.120.520.150.290.120.060.090.50.210.10.4-0.080.41
0.840.850.880.880.90.610.980.69-0.990.87-0.090.740.840.760.880.80.970.850.880.760.950.870.810.990.81
0.440.690.560.590.40.070.770.99-0.680.6-0.660.740.650.250.60.460.590.680.630.230.530.650.360.760.36
0.931.00.950.960.820.780.910.54-0.910.980.120.840.650.870.980.950.871.00.960.830.860.990.90.880.91
0.970.840.930.920.920.970.780.14-0.850.910.520.760.250.870.910.950.870.840.890.990.90.880.990.770.99
0.980.980.991.00.870.810.910.51-0.941.00.150.880.60.980.910.980.920.980.990.90.90.990.960.90.96
0.990.950.980.980.860.90.860.36-0.890.980.290.80.460.950.950.980.880.950.970.940.880.970.980.840.98
0.920.860.930.920.970.760.950.52-0.990.910.120.970.590.870.870.920.880.860.920.880.990.890.910.970.91
0.921.00.950.960.790.750.920.59-0.90.980.060.850.681.00.840.980.950.860.960.810.850.990.890.890.9
0.970.961.01.00.850.770.910.54-0.930.990.090.880.630.960.890.990.970.920.960.890.890.980.940.90.94
0.970.810.930.910.930.950.760.13-0.840.890.50.760.230.830.990.90.940.880.810.890.890.860.990.760.98
0.920.850.910.90.990.80.940.45-0.980.890.210.950.530.860.90.90.880.990.850.890.890.880.920.950.92
0.950.990.980.990.830.780.920.56-0.921.00.10.870.650.990.880.990.970.890.990.980.860.880.930.90.93
1.00.890.970.960.920.930.830.26-0.890.950.40.810.360.90.990.960.980.910.890.940.990.920.930.831.0
0.860.890.890.890.90.640.990.7-0.990.89-0.080.990.760.880.770.90.840.970.890.90.760.950.90.830.83
0.990.90.970.960.920.940.840.26-0.890.950.410.810.360.910.990.960.980.910.90.940.980.920.931.00.83
Click cells to compare fundamentals

Treace Medical Account Relationship Matchups

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.